Natural Capsules Ltd. (BSE: 524654) is a Bengaluru, Karnataka-based company in the Pharmaceuticals industry. With a market capitalisation of ₹169 Cr, it ranks #2,804 by market cap among the 6,137 Indian listed companies on FinBizNet, and #39 of 63 in Pharmaceuticals. At ₹142.82 (as of 25 Oct 2026), the share price is 39.0% below its 52-week high of ₹234.00 and 4.7% above its 52-week low of ₹136.36. The share price is down 36.9% over one year and down 4.1% over three months.
| Current Price | ₹142.82 |
|---|---|
| Market Cap | ₹169 Cr |
| BSE Code | 524654 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | -6.8 |
| Return on Equity | -10.03% |
| Return on Assets | -3.02% |
| 52-Week Range | ₹136.36 – ₹234.00 |
| 1-Year Price Change | -36.9% |
| 3-Month Price Change | -4.1% |
| Beta (1Y) | 0.79 |
| Dividend Yield | 0.00% |
| Headquarters | Bengaluru, Karnataka |
| Website | www.naturalcapsules.com |
| Revenue | ₹49 Cr |
|---|---|
| Net Profit | ₹-6 Cr |
| Net Margin | -11.8% |
| EPS (Basic) | ₹-5.55 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Natural Capsules Limited engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy free gelatin, shiny gelatin, sodium lauryl sulfate free gelatin, halal certified gelatin, fast release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form. Natural Capsules Limited was incorporated in 1993 and is based in Bengaluru, India.
1. Manufacture of Capsules-This segment manufactures hard capsules for pharmaceutical and dietary supplement industries. 2. Capsules-This segment manufactures hard gelatin capsule shells, hard cellulose capsule shells, and pharmaceutical dosage forms in capsule dosage form. 3. Segment Adjustment-0 4. Formulation-This segment is involved in formulating the pharmaceutical dosage forms in capsule dosage form, both pharma and neutraceutical products.
1. Capsules-92.8% 2. API-7.2%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹55,577 Cr | 35.5 | 34.46% | ₹1,814 Cr | -16.1% |
| Ajanta Pharma Limited | ₹41,591 Cr | 39 | 25.39% | ₹1,626 Cr | +36.3% |
| Emcure Pharmaceuticals Ltd | ₹34,533 Cr | 36.3 | 19.57% | ₹2,580 Cr | +31.1% |
| Piramal Pharma Ltd | ₹26,284 Cr | -79 | -4.00% | ₹2,270 Cr | -1.6% |
| RUBICON RESEARCH LIMITED | ₹24,972 Cr | 97.6 | 19.14% | ₹534 Cr | — |
| Caplin Point Laboratories Ltdte | ₹17,484 Cr | 26.9 | 19.94% | ₹610 Cr | +10.3% |
| Pfizer Ltd. | ₹17,448 Cr | 24.1 | 17.16% | ₹653 Cr | -32.1% |
| Eris Lifesciences Ltd | ₹15,877 Cr | 24.8 | 18.07% | ₹873 Cr | -30.8% |
| Natural Capsules Ltd. | ₹169 Cr | -6.8 | -10.03% | ₹49 Cr | -36.9% |
Listed by market capitalisation. Ratios are shown for context only.
Natural Capsules Ltd. is trading at ₹142.82, with a market capitalisation of ₹169 Cr.
Natural Capsules Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Natural Capsules Ltd. has a P/E of -6.8 and a return on equity of -10.03%.
Natural Capsules Ltd. is listed on the BSE under the scrip code 524654.
Natural Capsules Ltd.'s share price is down 36.9% over one year and down 4.1% over three months. Its 52-week range is ₹136.36 to ₹234.00.
In Q1 FY27, Natural Capsules Ltd. reported revenue of ₹49 Cr and net profit of ₹-6 Cr, with basic EPS of ₹-5.55 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.